Stephen M Simes - Net Worth and Insider Trading

Stephen M Simes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen M Simes owns 3 companies in total, including CervoMed Inc (CRVO) , ANI Pharmaceuticals Inc (ANIP) , and CytoDyn Inc (CYDY) .

Click here to see the complete history of Stephen M Simes’s form 4 insider trades.

Insider Ownership Summary of Stephen M Simes

Ticker	Comapny	Transaction Date	Type of Owner
CRVO	CervoMed Inc	2014-03-05	director & Chief Executive Officer
ANIP	ANI Pharmaceuticals Inc	2003-08-04	director & Vice Chairman & Pres. and CEO
CYDY	CytoDyn Inc	2022-10-13	director

Stephen M Simes Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Stephen M Simes Ownership Network

Ownership Network List of Stephen M Simes

No Data

Ownership Network Relation of Stephen M Simes

Stephen M Simes Owned Company Details

What does CervoMed Inc do?

Who are the key executives at CervoMed Inc?

Stephen M Simes is the director & Chief Executive Officer of CervoMed Inc. Other key executives at CervoMed Inc include director & 10 percent owner Sylvie Gregoire , Chief Financial Officer John William Tanner , and VP & Clinical Development Kelly Blackburn .

CervoMed Inc (CRVO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CervoMed Inc (CRVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CervoMed Inc (CRVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CervoMed Inc (CRVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

CervoMed Inc Insider Transactions

No Available Data

What does ANI Pharmaceuticals Inc do?

Who are the key executives at ANI Pharmaceuticals Inc?

Stephen M Simes is the director & Vice Chairman & Pres. and CEO of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include Vice President and CFO Stephen P. Carey , SVP - CORP. DEV. & STRATEGY Chad Gassert , and HEAD OF RARE DISEASE Christopher Mutz .

ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary

Over the past 18 months, Stephen M Simes made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 676,190 shares made by Muthusamy Shanmugam , a net sale of 180,000 shares made by Chad Gassert , and a net sale of 1,750 shares made by Meredith Cook .

In summary, during the past 3 months, insiders sold 333,801 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 333,801 shares. During the past 18 months, 1,287,027 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,287,027 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

ANI Pharmaceuticals Inc Insider Transactions

No Available Data

What does CytoDyn Inc do?

Who are the key executives at CytoDyn Inc?

Stephen M Simes is the director of CytoDyn Inc. Other key executives at CytoDyn Inc include EVP of Legal Affairs Tyler Blok , President Arvin Cyrus Arman , and Chief Financial Officer Antonio Migliarese .

CytoDyn Inc (CYDY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of CytoDyn Inc (CYDY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CytoDyn Inc (CYDY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

CytoDyn Inc (CYDY)'s detailed insider trading history can be found in Insider Trading Tracker table.

CytoDyn Inc Insider Transactions

No Available Data

Stephen M Simes Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen M Simes. Currently GuruFocus does not have mailing address information for Stephen M Simes.

Discussions on Stephen M Simes

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.